️ President Shavkat Mirziyoyev of Uzbekistan has proposed a support mechanism for enterprises ready to quickly master the production of in-demand medicines whose original versions were created decades ago. The state will compensate half of the costs for technology transfer, which is claimed to reduce the price of foreign drugs by several times.

️ According to the press secretary of the Uzbek leader, Sherzod Asadov, the president instructed at a meeting to stimulate the production of generics—drugs that other companies can produce 20-30 years after the original creation. Such medicines, in high demand, will be supplied to the domestic market at prices that could be five times lower than imported equivalents.

️ For companies that launch production within a year, the state, through the Pharmaceutical Fund, will compensate 50% of the expenses for technology transfer. For entrepreneurs ready to increase the production of the 100 most imported items, the territory of the "Tashkent Pharma Park" cluster will be expanded by another 100 hectares.

️ The head of state also clarified that South Korean partners have offered to take over an additional 60 hectares for management, are prepared to invest $40 million in infrastructure, and attract leading Korean companies. Responsible officials have been tasked with completing negotiations and forming projects in biopharmaceuticals and cosmetics worth at least $400 million.

️ It was previously reported that the president called on the largest drug importers to establish drug production in Uzbekistan.

Source: podrobno.uz